• Join
  • Login
  • Contact

Search abstracts

Pharmacovigilance: a responsibility shared or someone else’s problem? lessons from nimesulide.

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Poster
  • By: HENMAN, Martin (Trinity College Dublin, Dublin, Ireland)
  • Abstract:

    Suspension of a drug's Marketing Authorisation because of serious adverse drug reactions (ADRs) has tragic consequences for patients and it raises questions concerning the protection of public health. Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) authorised for the relief of the symptoms of osteoarthritis, dental pain and


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses